Site-dependent production of transforming growth factor β1 in colonic mucosa: Its possible role in tumorigenesis of the colon

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 3, 2000, Pages 201-208

  Kushiyama, Yoshinori ^a   Fukuda, Ryo ^a   Suetsugu, Hiroshi ^a   Kazumori, Hideaki ^a   Ishihara, Shunji ^a   Adachi, Kyoichi ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLON; ENZYME IMMUNOASSAY; MUCOSA; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR DIAGNOSIS;

EID: 0033797059     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.108755     Document Type: Article

References (34)

1. The cell biology of transforming growth factor β
2. TGF-β expression in the human colon: Differential immunostaining along crypt epithelium
3. Inward growth of colorectal adenomatous polyps
4. Locarization of transforming growth factor β isoforms in the normal murine small intestine and colon
5. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
6. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): Conversion of an adenoma cells into a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effect of TGF-β
7. Trasforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells
8. Epidemiology of colorectal adenomatous polyps
9. The national cancer data base report on colon cancer
10. Methylation of the oestrogen receptor CpG island links againg and neoplasia in human colon
11. Organ culture of human rectal mucosa
12. Evidence that predonisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa
13. In vitro model for the assessment of luminal factors on rectal mucosa
14. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease
15. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line
16. TGF-β expression in the human colon: Differential immunostaining along crypt epithelium
17. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease
18. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients
19. Cytokine mRNA expression in intestinal tissue of interleukin-2-deficient mice with bowel inflammation
20. Alteration of gene expression by epithelial cells precedes colitis in interleukin-2-deficient mice
21. Regulation of intestinal epithelial barrier function by TGF-β1
22. Apoptosis in colorectal tumor cells; Induction by the short chain fatty acids butyrate, proprionate and acetate, and by the bile salt deoxycholate
23. Reduced bile acid-induced apoptosis in 'normal' colorectal mucosa: A potential biological marker for cancer risk
24. Transforming growth factor-β
25. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death
26. TGF-β production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice
27. Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats
28. Inhibition of apoptosis during development of colorectal cancer
29. Inhibition of endothelial cell movement by pericytes or smooth mucsle cells: Activation of a latent transforming growth factor-β1-like molecules by plasmin during coculture
30. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells
31. Transforming growth factor β1 suppresses nonmetaplastic colon cancer at an early stage of tumorigeneis
32. A controlled release of TGF-β1 impedes rat colon carcinogenesis in vivo
33. The polyp-cancer sequence in the large bowel
34. A genetic model for colorectal tumorigenesis